Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 1, 2006, Pages 112-124

  Hope, Andrew J ^a   Lindsay, Patricia E ^a   El Naqa, Issam ^a   Alaly, James R ^a   Vicic, Milos ^a   Bradley, Jeffrey D ^a   Deasy, Joseph O ^a  

^a USA   (United States)

Author keywords

Lung cancer; Modeling; NTCP; Radiation pneumonitis; Radiotherapy

Indexed keywords

DOSIMETRY; MATHEMATICAL MODELS; PARAMETER ESTIMATION; PATIENT MONITORING; RISK ASSESSMENT; TUMORS;

LUNG CANCER; MODELING; NTCP; RADIATION PNEUMONITIS;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DOSIMETRY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RISK ASSESSMENT; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 33646015056     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.11.046     Document Type: Article

References (69)

1. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
2. Armstrong J.G., Zelefsky M.J., Leibel S.A., et al. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol 6 (1995) 693-697
3. Belderbos J.S., De Jaeger K., Heemsbergen W.D., et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 66 (2003) 119-126
4. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy. update of a phase I trial. J Clin Oncol 19 (2001) 127-136
5. Rosenzweig K.E., Fox J.L., Yorke E., et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer 103 (2005) 2118-2127
6. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311. A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
7. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 8 (1985) S13-S19
8. Abraatt R.P. Clinical dose-volume histogram and lung toxicity after irradiation for lung cancer. Int J Radiat Oncol Biol Phys 47 (2000) 1461
9. Armstrong J.G. Three-dimensional conformal radiotherapy. Precision treatment of lung cancer. Chest Surg Clin N Am 4 (1994) 29-43
10. Yorke E.D., Kutcher G.J., Jackson A., et al. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol 26 (1993) 226-237
11. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose. An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
12. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity. A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
13. Fu X.L., Huang H., Bentel G., et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys 50 (2001) 899-908
14. Seppenwoolde Y., Lebesque J.V., de Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
15. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54 (2002) 329-339
16. Kwa S.L., Theuws J.C., Wagenaar A., et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 48 (1998) 61-69
17. Willner J., Jost A., Baier K., et al. A little to a lot or a lot to a little?. An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 179 (2003) 548-556
18. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
19. Yamada M., Kudoh S., Hirata K., et al. Risk factors of pneumonitis following chemoradiotherapy for lung cancer. Eur J Cancer 34 (1998) 71-75
20. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 110-115
21. Yu X., Zhou S.M., Khan D., et al. Predicting RT-induced pulmonary symptoms based on the dose to the superior vs. inferior lung in patients irradiated for lung cancer. Int J Radiat Biol 57 (2003) S415
22. Roach III M., Gandara D.R., Yuo H.S., et al. Radiation pneumonitis following combined modality therapy for lung cancer. Analysis of prognostic factors. J Clin Oncol 13 (1995) 2606-2612
23. Koga K., Kusumoto S., Watanabe K., et al. Age factor relevant to the development of radiation pneumonitis in radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 14 (1988) 367-371
24. Schild S.E., Stella P.J., Geyer S.M., et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 21 (2003) 3201-3206
25. Claude L., Perol D., Ginestet C., et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer. Clinical and dosimetric factors analysis. Radiother Oncol 71 (2004) 175-181
26. Monson J.M., Stark P., Reilly J.J., et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 82 (1998) 842-850
27. Abratt R.P., and Willcox P.A. The effect of irradiation on lung function and perfusion in patients with lung cancer. Int J Radiat Oncol Biol Phys 31 (1995) 915-919
28. Boersma L.J., Damen E.M., de Boer R.W., et al. Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury. Radiother Oncol 36 (1995) 15-23
29. Marks L.B., Munley M.T., Spencer D.P., et al. Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys 38 (1997) 399-409
30. Robnett T.J., Machtay M., Vines E.F., et al. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 48 (2000) 89-94
31. Brooks Jr. B.J., Seifter E.J., Walsh T.E., et al. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer. J Clin Oncol 4 (1986) 200-209
32. Rancati T., Ceresoli G.L., Gagliardi G., et al. Factors predicting radiation pneumonitis in lung cancer patients. A retrospective study. Radiother Oncol 67 (2003) 275-283
33. Byhardt R.W., Scott C., Sause W.T., et al. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 42 (1998) 469-478
34. Fernando I.N., Powles T.J., Ashley S., et al. An acute toxicity study on the effects of synchronous chemotherapy and radiotherapy in early stage breast cancer after conservative surgery. Clin Oncol (R Coll Radiol) 8 (1996) 234-238
35. Nishioka A., Ogawa Y., Hamada N., et al. Analysis of radiation pneumonitis and radiation-induced lung fibrosis in breast cancer patients after breast conservation treatment. Oncol Rep 6 (1999) 513-517
36. Segawa Y., Takigawa N., Kataoka M., et al. Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer. Int J Radiat Oncol Biol Phys 39 (1997) 91-98
37. Taghian A.G., Assaad S.I., Niemierko A., et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 93 (2001) 1806-1811
38. Anscher M.S., Kong F.M., Andrews K., et al. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 41 (1998) 1029-1035
39. Barthelemy-Brichant N., Bosquee L., Cataldo D., et al. Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys 58 (2004) 758-767
40. Chen Y., Hyrien O., Williams J., et al. Interleukin (IL)-1A and IL-6. Applications to the predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys 62 (2005) 260-266
41. Seppenwoolde Y., De Jaeger K., Boersma L.J., et al. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 748-758
42. Liao Z.X., Travis E.L., and Tucker S.L. Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung. Int J Radiat Oncol Biol Phys 32 (1995) 1359-1370
43. Travis E.L., Liao Z.X., and Tucker S.L. Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys 38 (1997) 1045-1054
44. Khan M.A., Van Dyk J., Yeung I.W., et al. Partial volume rat lung irradiation. Assessment of early DNA damage in different lung regions and effect of radical scavengers. Radiother Oncol 66 (2003) 95-102
45. Moiseenko V.V., Battista J.J., Hill R.P., et al. In-field and out-of-field effects in partial volume lung irradiation in rodents. Possible correlation between early DNA damage and functional endpoints. Int J Radiat Oncol Biol Phys 48 (2000) 1539-1548
46. Karnofsky D.A., and Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod C.M. (Ed). Evaluation of chemotherapeutic agents (1949), Columbia University Press, New York 191-205
47. Green S., and Weiss G.R. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 10 (1992) 239-253
48. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
49. Deasy J.O., Blanco A.I., and Clark V.H. CERR. A computational environment for radiotherapy research. Med Phys 30 (2003) 979-985
50. Niemierko A. Reporting and analyzing dose distributions. A concept of equivalent uniform dose. Med Phys 24 (1997) 103-110
51. Zar J.H. Biostatistical analysis. 2nd ed. (1984), Prentice-Hall, Englewood Cliffs, NJ
52. El Naqa I., Bradley J., Blanco A.I., et al. Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys 64 (2006) 1275-1286
53. Rubin P., Johnston C.J., Williams J.P., et al. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 33 (1995) 99-109
54. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28 (1994) 575-581
55. Oetzel D., Schraube P., Hensley F., et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33 (1995) 455-460
56. Fay M., Tan A., Fisher R., et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1355-1363
57. Gopal R., Tucker S.L., Komaki R., et al. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56 (2003) 106-113
58. Murray J.F., and Nadel J.A. Textbook of respiratory medicine. 2nd ed. (1994), Saunders, Philadelphia
59. Byhardt R.W., Martin L., Pajak T.F., et al. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)-Analysis of a Radiation Therapy Oncology Group (RTOG) protocol. Int J Radiat Oncol Biol Phys 27 (1993) 537-544
60. Seppenwoolde Y., Shirato H., Kitamura K., et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys 53 (2002) 822-834
61. Jackson A., Kutcher G.J., and Yorke E.D. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys 20 (1993) 613-625
62. Tucker S.L., Liao Z.X., and Travis E.L. Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys 38 (1997) 1055-1066
63. Jenkins P., D'Amico K., Benstead K., et al. Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART). Int J Radiat Oncol Biol Phys 56 (2003) 360-366
64. Dawson L.A., Biersack M., Lockwood G., et al. Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation. Int J Radiat Oncol Biol Phys 62 (2005) 829-837
65. Ahnesjo A., and Aspradakis M.M. Dose calculations for external photon beams in radiotherapy. Phys Med Biol 44 (1999) R99-R155
66. Lindsay P.E., El Naqa I., Hope A.J., et al. Monte Carlo based retrospective dose calculations for outcomes modeling. abstract. Med Phys 32 (2005) 2114
67. International Commission on Radiation Units and Measurements. Report 62. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50) (1999), ICRU, Bethesda
68. Han B.H., and Wallner K.E. Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications. Int J Cancer 96 (2001) 372-378
69. Ishikawa S., Otsuki T., Kaneki M., et al. Dose-related effects of single focal irradiation in the medial temporal lobe structures in rats-Magnetic resonance imaging and histological study. Neurol Med Chir (Tokyo) 39 (1999) 1-7